How to structure your physical activity on GLP-1 medication — including why resistance training matters more than cardio, and how to manage energy during dose escalation.
This guide has been reviewed by a licensed exercise physiologist and reflects current clinical evidence on physical activity during GLP-1 therapy. Consult your provider before starting a new exercise program.
GLP-1 medications reduce appetite and total calorie intake. Without exercise — specifically resistance training — a significant portion of the weight you lose will be muscle mass, not fat. Research shows that in patients losing weight through caloric restriction alone, 25–40% of total weight lost can be lean body mass.
Muscle mass is metabolically active — it burns calories at rest, supports insulin sensitivity, and is closely associated with longevity and quality of life. Losing it during GLP-1 therapy creates a metabolic disadvantage that makes weight maintenance significantly harder once treatment ends.
If your time and energy are limited — and on GLP-1, energy often is limited during dose escalation — here's how to prioritize:
Many patients make the mistake of focusing on cardio (treadmill, cycling) because it "burns more calories." On GLP-1 therapy, resistance training is the higher-priority intervention because its primary benefit is muscle preservation — not calorie burn.
Any exercise that makes your muscles work against a load or resistance: free weights, machines, resistance bands, bodyweight exercises (push-ups, squats, lunges), or functional training classes. The key is progressive overload — gradually increasing difficulty over time.
If you're new to strength training, start with 2 full-body sessions per week and build from there:
The first 4–8 weeks of GLP-1 therapy — when doses are increasing — are often the hardest energetically. Nausea, reduced food intake, and the adjustment period can leave you feeling fatigued.
Daily walking is one of the most evidence-backed low-intensity interventions for metabolic health. It improves insulin sensitivity, supports fat oxidation, reduces cardiovascular risk, and generates NEAT (non-exercise activity thermogenesis) that adds meaningfully to daily calorie expenditure.
Aim for 7,000–10,000 steps per day as a baseline. Even 30 minutes of walking after dinner has been shown to meaningfully improve post-meal blood glucose levels — highly relevant for GLP-1 patients with metabolic syndrome or pre-diabetes.
GLP-1 therapy already creates a significant caloric deficit. Adding excessive cardio on top of this (especially without adequate protein and sleep) accelerates muscle loss rather than fat loss. More exercise is not always better. Adequate recovery is essential.